Attached files
| file | filename |
|---|---|
| EX-31 - PROTECT PHARMACEUTICAL Corp | exhibit31.htm |
| 10-K - PROTECT PHARMACEUTICAL Corp | prttform10kv2cleansgacomment.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Protect Pharmaceutical Corporation (the “Company”) on Form 10-K for the period ending December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Una Taylor, Chief Executive Officer and Acting Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/s/ UNA TAYLOR
Una Taylor
Chief Executive Officer
Principal Accounting Officer
March 31, 2017